It is a pharma private limited company based in Satara, Maharashtra, India, established in 2014.
2014 | Satara, Maharashtra, India | ActiveEbullient Pharmaceuticals Private Limited, a active private limited company, was established on 24 March 2014 in Satara, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U36932PN2014PTC151132. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹7.76 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Kailash Maruti Khadatare (Director), Sanjay Krishna Ghorpade (Director), Vandana Sanjay Ghorapade (Director). Past directors included Kailash Maruti Khadatare, Minakshi Kailash Khadatare, Deepak Dinkar Thorat. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.F-4 Dhanashree Hights 579 Guruwar Peth Satra, Satara, Maharashtra, 415002.
U36932PN2014PTC151132
151132
24 March 2014
₹2.00 Cr
₹7.76 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Ebullient Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kailash Maruti Khadatare | Director | 21 Dec 2014 | Current |
| Sanjay Krishna Ghorpade | Director | 21 Dec 2014 | Current |
| Vandana Sanjay Ghorapade | Director | 21 Dec 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 02 Jan 2015 | Past |
| Pramod Abcsdd | Additional Director | 02 Jan 2015 | Past |
| Pramod Abcsdd | Managing Director | 16 May 2018 | Past |
| Pramod Abcsdd | Managing Director | 01 Aug 2017 | Past |
| Pramod Abcsdd | Director | 01 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 02 Jan 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ebullient Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.29% increase. The company also saw a substantial improvement in profitability, with a 28.68% increase in profit. The company's net worth dipped by a decrease of 5.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Ebullient Pharmaceuticals had a promoter holding of 95.24% and a public holding of 4.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ebullient Pharmaceuticals has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ebullient Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ebullient Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ebullient Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Ebullient Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
Kailash Maruti Khadatare was appointed as a Director was appointed as a Director on 21 Dec 2014 & has been associated with this company since 10 years 11 months . was recorded as a recent event.
The activity Sanjay Krishna Ghorpade was appointed as a Director was appointed as a Director on 21 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
The activity Vandana Sanjay Ghorapade was appointed as a Director was appointed as a Director on 21 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
The activity Ebullient Pharmaceuticals Private Limited was registered on 24 Mar 2014 with Roc Pune & aged 11 years 8 months as per MCA records. was completed.
The CIN of Ebullient Pharmaceuticals Private Limited is U36932PN2014PTC151132.
Ebullient Pharmaceuticals Private Limited is headquartered at Flat No.F-4 Dhanashree Hights 579 Guruwar Peth Satra, Satara, Maharashtra, 415002.
Ebullient Pharmaceuticals Private Limited was incorporated on 24 March 2014.
The current directors of Ebullient Pharmaceuticals Private Limited are
The primary industry of Ebullient Pharmaceuticals Private Limited is Manufacturing.
Ebullient Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ebullient Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹7.76 M.
The compliance status of Ebullient Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX